ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

3,4'-ジクロロ[1,1'-ビフェニル]

3,4'-Dichlorobiphenyl

HCID 18101
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
2974-90-5
標準SMILES
Clc1ccc(-c2cccc(Cl)c2)cc1
InChIKey
CJDNEKOMKXLSBN-UHFFFAOYSA-N
分子式
C12H8Cl2
平均分子量
223.09 g/mol
単同位体質量
222.0003056

概要

3,4'-Dichlorobiphenyl is one of 209 polychlorinated biphenyls (PCBs). PCBs are a group of synthetic organic compounds with 1-10 chlorine atoms attached to biphenyl. They were manufactured as commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4)

名称と識別子

優先名称
3,4'-Dichlorobiphenyl
IUPAC
1-chloro-3-(4-chlorophenyl)benzene
現地名
3,4'-ジクロロ[1,1'-ビフェニル]
英語名
3,4'-Dichlorobiphenyl
分子式
C12H8Cl2
分子量
223.1

名称と別名

3,4'-DICHLOROBIPHENYL2974-90-53,4'-Dichloro-1,1'-biphenyl1,1'-Biphenyl, 3,4'-dichloro-PCB 13UNII-3Q041BH8IG3Q041BH8IGDTXSID10863067RefChem:53576DTXCID908117431-chloro-3-(4-chlorophenyl)benzene3,4/'-Dichlorobiphenyl
名称をさらに表示
3,4'-ジクロロ-1,1'-ビフェニル3,4'-ジクロロ[1,1'-ビフェニル]3,4'-ジクロロビフェニル3,4′‐ジクロロビフェニル標準品3,4′‐ジクロロビフェニル標準液3,4'-ジクロロビフェニル, 100 µg/mL in Isooctane3,4′-ジクロロ-1,1′-ビフェニル3,4′-ジクロロ[1,1′-ビフェニル]3,4′-ジクロロビフェニルPCB-133,4′-ジクロロビフェニル標準液3,4'-CBBZNO 13PCB NO 13PCB13 in CyclohexanePhloroglucinol Impurity 1231-chloro-4-(3-chlorophenyl)benzene
PCB No. 131,1'-Biphenyl, ar,ar'-dichloro-33039-81-5SCHEMBL435265SCHEMBL436851SCHEMBL1520884SCHEMBL15063921SCHEMBL27682609

物性

構造計算による物性

XLogP
5.2
極性表面積
0 Ų
水素結合供与体数
0
水素結合受容体数
0
回転可能結合数
1
重原子数
14
形式電荷
0
複雑度
173

実験および物理化学的性質

LogP5.15

物理化学的性質

沸点
125 °C · 125 °C(Press: 1 Torr)
比重(密度)
1.249 · 1.249±0.06 g/cm3(Predicted)
Henry's Law Constant
4.9 · 4.9×10-2 mol/(m3Pa) at 25℃, Bamford et al. (2002)
EPAの化学物質情報
3 · 3,4'-Dichlorobiphenyl (2974-90-5)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 3 件

This chemical does not meet GHS hazard criteria for 100% (3 of 3) of all reports.

Not Classified

Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesNot Classified

安全と保護具

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

毒性情報

Treatment · 1 件

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 件

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Exposure RoutesOral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 件

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

用途と製造

Uses · 1 件

PCBs were as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

応用分野

使用3,4''-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

サプライヤー15 社

阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
郑州阿尔法化工有限公司+86-18530059196 · [email protected]
安徽合诺生物科技有限公司0555-2761852
安徽合诺生物科技有限公司18455579438
上海稳同科技有限公司

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
2974-90-5、33039-81-5
PubChem CID
18101
DTXSID
DTXSID10863067
UNII
3Q041BH8IG
EC Number
690-126-8
Nikkaji
J80.604H
Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

安全データ

化審法
-1
安衛法
特定化学物質障害予防規則:第1類物質,57,57-2
消防法
危-4-1-II
02151600108 13062666369 · [email protected]
上海毕楷科技有限公司18516304666 · [email protected]
天津阿尔塔科技有限公司022-65378550-8551 · [email protected]
天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
广东元丰化学试剂有限公司0751-2829979 13318584237 · [email protected]
青岛腾龙微波科技有限公司0532-83818797 17669478191 · [email protected]
广东翁江化学试剂有限公司0751-2815983 13927872582 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
珠海奥博凯生物医药技术有限公司400-0628126 · [email protected]